Home » Topics » Regulatory

Regulatory
RSS

FDA approves Rexulti for schizophrenia and major depressive disorder

July 13, 2015

FDA approves Entresto to reduce risk of cardiovascular death and heart failure hospitalization

July 8, 2015

Olanedine antiseptic approved in Japan

July 7, 2015

Strensiq receives first approval in Japan for hypophosphatasia

July 7, 2015

Acoalan approved in Japan

July 6, 2015

FDA grants approval to Orkambi for cystic fibrosis

July 3, 2015

FDA approves Tuxarin ER

July 3, 2015

European approval of Simponi for non-radiographic axial spondyloarthritis

June 29, 2015

Radicut approved in Japan for amyotrophic lateral sclerosis

June 29, 2015

FDA approves Rapamune for lymphangioleiomyomatosis

June 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...